Diagnosis, pathophysiology and management of children with refractory immune thrombocytopenic purpura Review uri icon

Overview

MeSH Major

  • Purpura, Thrombocytopenic, Idiopathic

abstract

  • Management of refractory immune thrombocytopenic purpura often requires multiple agents that may provide only short-term benefit. Lack of clear views about the use of these medications, their unwanted side effects and an inability to specifically target a particular patient's disease all lead to frustration among patients, family and the physicians. Better understanding of pathogenesis with the availability of newer therapies with different mechanisms of effect should, however, allow improved management of these patients.

publication date

  • February 2008

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/MOP.0b013e3282f45bb9

PubMed ID

  • 18197033

Additional Document Info

start page

  • 8

end page

  • 16

volume

  • 20

number

  • 1